-
March 13, 2018
Comments (0)
Blog, Current Investigations
Investor Alert: Orexigen Therapeutics Inc. Orexigen Therapeutics Inc (OREX.O) announced last Monday it filed for Chapter 11 bankruptcy protection and will also file a motion to pursue an auction and sale process of substantially all its assets. The biopharmaceutical company, which focuses on the treatment of obesity,
Read More »
-
February 13, 2018
Comments (0)
Blog
Concerned about your investment in Orexigen Therapeutics Inc.? According to Bloomberg, Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company
Read More »
